It sounds like the FDA might almost be ready to throw its hands up and walk away, something leadership may have been contemplating all along, given that in 2011, the agency circulated a draft guidance that really didn’t say much anyway. The 2013 final version clarified policy a bit, stating that the FDA generally would focus only on mobile apps that serve as medical devices, and mostly stay away from regulating consumer technology.
Read Full Article »
